Tokyo, Japan

Hideyuki Shiozawa

This inventor holds 3 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideyuki Shiozawa. Retrieved from https://idiyas.com/inventor/hideyuki-shiozawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hideyuki Shiozawa

Introduction

Hideyuki Shiozawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of antibacterial compounds, holding a total of 3 patents. His work focuses on the genus Alteromonas, which has implications for medical and pharmaceutical applications.

Latest Patents

Shiozawa's latest patents include a novel antibacterial compound derived from Alteromonas, which shares structural similarities with pseudomonic acids. This invention presents a promising avenue for developing new antibacterial agents. Additionally, he has developed two thiomarinol derivatives, named 'thiomarinol B' and 'thiomarinol C', which exhibit antibacterial and anti-mycoplasmal properties. Thiomarinol B can also be synthesized through the oxidation of thiomarinol.

Career Highlights

Shiozawa is currently associated with Sankyo Company, Limited, where he continues to innovate in the field of microbiology and pharmaceuticals. His research has the potential to impact the treatment of bacterial infections significantly.

Collaborations

Some of his notable coworkers include Shuji Takahashi and Takeshi Kagasaki, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Hideyuki Shiozawa's work in developing antibacterial compounds from Alteromonas showcases his innovative spirit and dedication to advancing medical science. His contributions are paving the way for new treatments in the fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…